| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |